Category: carcinoid
Governor of Missouri Proclaims November 10, 2010 Neuroendocrine Cancer Awareness Day
In recognition of the first Worldwide NET Cancer Awareness Day, Jeremiah W. (Jay) Nixon, Governor of Missouri, has declared November 10, 2010 to be Neuroendocrine Cancer Awareness Day. In his proclamation, Governor Nixon talked about the importance…
READ MORE
A Carcinoid Soldier’s Survivor Story
When Staff Sergeant Daniel Barber of D Company 1-106th AVN in the Missouri National Guard was first diagnosed with carcinoid cancer in 2009 he experienced feelings of shock, despair, anger, fear and frustration. But he was also relieved because he knew…
READ MORE
iWalk for Carcinoid
iWalk for Carcinoid is a virtual walkathon to help raise money for carcinoid-related organizations. The Carcinoid Cancer Foundation is one of the organizations selected to benefit from this virtual walkathon. Each organization has the opportunity…
READ MORE
2012 National Carcinoid & NETs Conference: Save the Date
Dr. Eugene A. Woltering, the Carcinoid Cancer Awareness Network (CCAN), and the New Orleans Neuroendocrine Tumor Specialist team at Ochsner Medical Center – Kenner in Louisiana have announced the dates for the 2012 National Carcinoid/NETs Conference…
READ MORE
NY Islanders Team Up with Carcinoid Cancer Awareness Network
The New York Islanders ice hockey team will join with the Carcinoid Cancer Awareness Network (CCAN) on Wednesday, December 22nd in the fight against carcinoid and neuroendocrine cancers. The 7 pm game at the Nassau Coliseum in Hempstead, New York, will…
READ MORE
Lexicon Pharmaceuticals, Inc. Clinical Trial Recruiting Carcinoid Syndrome Patients
Patients with carcinoid syndrome, whose symptoms are not managed by octreotide therapy, are being recruited for a Phase 2 clinical trial of Lexicon Pharmaceuticals’ LX1606 (a.k.a. LX1032). The trial has been given Fast Track status in the U.S. and …
READ MORE
FDA Approves Novel Radio-peptide Targeted Therapy Clinical Trial for Neuroendocrine Cancer: PRRT (Peptide Receptor Radionuclide Therapy)
For the first time in North America, neuroendocrine cancer patients will have the opportunity to participate in a clinical trial of Lutetieum-177 (LU-177)with Octreotate. Ebrahim S. Delpassand, MD, chief executive officer and medical director of…
READ MORE
10 More iPhone Apps for Patients and Physicians
If you are a carcinoid or neuroendocrine cancer iPhone user, a healthcare provider who treats carcinoid/NETs patients, or a medical student, here are 10 more iPhone apps that will give you information about everything from new drug warnings to places…
READ MORE
Worldwide NET (Neuroendocrine Tumor) Cancer Awareness Day Website Goes Live
A new website, www.netcancerday.org, has just gone live to launch an international campaign to bring about greater awareness of neuroendocrine cancers. The first Worldwide NET Cancer Awareness Day (WNCAD) will take place on November 10, 2010. The…
READ MORE
Carcinoid Cancer Foundation Welcomes Channeling Jackie-O
When Marlena Johnston was first diagnosed with carcinoid cancer of the appendix in April 2010, she went to the Carcinoid Cancer Foundation’s website and embarked on a journey to learn all she could about her rare disease. She began with Newly Diagnosed:…
READ MORE
